For purchasing or obtaining a quotation, please visit the Distributor page
to find your local distributor.
to find your local distributor.
HOME > Product search results
Searched by
MHC Allele - A*02:01
Product（484）
[-] MHC tetramer（484）
>Class I（484）
Refine your search
[+]Animal species
[+]Category
[+]Conjugate
[+]MHC Allele
[+]Research area
[+]Tools
[+]Brands
[+]Availability (in Japan)
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TS-M047-2 |
HLA-A*02:01 HPV16 E6 Tetramer-KLPQLCTEL-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests | 1-9 | |
| KLPQLCTEL | 18-26 | ４°C | ||||
|
|
TC-0169-2 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GVRGRVEEI | ４°C | |||||
|
|
TS-M075-4 |
HLA-A*02:01 MAGE-A3 112-120 Tetramer-KVAELVHFL-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVAELVHFL | 112-120 | ４°C | ||||
|
|
TS-M051-2 |
HLA-A*02:01 HBV env 335-343 Tetramer-WLSLLVPFV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| WLSLLVPFV | 335-343 | ４°C | ||||
|
|
TC-0158-4 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFLGILSV | 188-196 | ４°C | ||||
|
|
TC-0170-4 |
HLA-A*02:01 IAPP Tetramer-KLQVFLIVL-BV421 |
|
|||
|
|
Others | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLQVFLIVL | 5-13 | ４°C | ||||
|
|
TS-0035-4C |
HLA-A*02:01 gp100 154-162 Tetramer-KTWGQYWQV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KTWGQYWQV | 154-162 | ４°C | ||||
|
|
TC-0155-2 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LTLGEFLKL | 96-104 | ４°C | ||||
|
|
TS-0031-4 |
HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPET-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMLDLQPET | 11-19 | ４°C | ||||
|
|
TS-0013-4C |
HLA-A*02:01 gp100 (mutant) Tetramer-IMDQVPFSV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| IMDQVPFSV | 209-217 | ４°C | ||||
|
|
TC-0134-1 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FVGEFFTDV | 144-152 | ４°C | ||||
|
|
TC-0170-1 |
HLA-A*02:01 IAPP Tetramer-KLQVFLIVL-PE |
|
|||
|
|
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLQVFLIVL | 5-13 | ４°C | ||||
|
|
TC-0151-2 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | ４°C | ||||
|
|
TC-0112-4 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLPLTVAEV | ４°C | |||||
|
|
TS-0014-4C |
HLA-A*02:01 gp100 (Wild) Tetramer-ITDQVPFSV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ITDQVPFSV | 209-217 | ４°C | ||||
|
|
TC-0174-1 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLNEVAKNL-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLNEVAKNL | ４°C | |||||
|
|
TC-0174-4 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLNEVAKNL-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLNEVAKNL | ４°C | |||||
|
|
TS-M017-4 |
HLA-A*02:01 HTLV-1 Tax11-19 Tetramer-LLFGYPVYV-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFGYPVYV | 11-19 | ４°C | ||||
|
|
TC-0134-2 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FVGEFFTDV | 144-152 | ４°C | ||||
|
|
TC-0158-1 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFLGILSV | 188-196 | ４°C | ||||
|
|
TC-0176-1 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-YLQPRTFLL-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQPRTFLL | ４°C | |||||
|
|
TS-M105-4 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests | 1-9 | |
| SLLMWITQV | 157-165 | ４°C | ||||
|
|
TC-0163-2 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | ４°C | ||||
|
|
TC-0175-2 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLPDDFTGCV | ４°C | |||||
|
|
TS-M115-4 |
HLA-A*02:01 hTERT Tetramer-ILAKFLHWL-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILAKFLHWL | ４°C | |||||
|
|
TC-0146-4 |
HLA-A*02:01 EBV LMP1 Tetramer-YLLEMLWRL-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLEMLWRL | 125-133 | ４°C | ||||
|
|
TS-0017-4 |
HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLQELNVTV | 169-177 | ４°C | ||||
|
|
TS-0017-2 |
HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLQELNVTV | 169-177 | ４°C | ||||
|
|
TC-0173-1 |
HLA-A*02:01 HPV16 E7 Tetramer-MLDLQPETT-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| MLDLQPETT | 12-20 | ４°C | ||||
|
|
TS-0017-1 |
HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLQELNVTV | 169-177 | ４°C | ||||
|
|
TC-0102-1 |
HLA-A*02:01 Insulin B Tetramer-HLVEALYLV-PE |
|
|||
|
|
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| HLVEALYLV | ４°C | |||||
|
|
TC-0107-4 |
HLA-A*02:01 IGRP Tetramer-LNIDLLWSV-BV421 |
|
|||
|
|
Others | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LNIDLLWSV | ４°C | |||||
|
|
TC-0132-4 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | ４°C | ||||
|
|
TC-0173-4 |
HLA-A*02:01 HPV16 E7 Tetramer-MLDLQPETT-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| MLDLQPETT | 12-20 | ４°C | ||||
|
|
TC-0116-1 |
HLA-A*02:01 LCMV GPC 447-455 Tetramer-YLVSIFLHL-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLVSIFLHL | ４°C | |||||
|
|
TC-0158-2 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFLGILSV | 188-196 | ４°C | ||||
|
|
TC-0165-1 |
HLA-A*02:01 Influenza M1 Tetramer-ILGFVFTLTV-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILGFVFTLTV | ４°C | |||||
|
|
TC-0161-2 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | ４°C | ||||
|
|
TS-M039-4 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CINGVCWTV-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| CINGVCWTV | 1073-1081 | ４°C | ||||
|
|
TC-0114-1 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQVNSLQTV | ４°C | |||||
|
|
TS-M016-4 |
HLA-A*02:01 WT1126-134 Tetramer-RMFPNAPYL-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| RMFPNAPYL | 126-134 | ４°C | ||||
|
|
TC-0107-1 |
HLA-A*02:01 IGRP Tetramer-LNIDLLWSV-PE |
|
|||
|
|
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| LNIDLLWSV | ４°C | |||||
|
|
TC-0162-1 |
HLA-A*02:01 IGRP Tetramer-VLFGLGFAI-PE |
|
|||
|
|
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLFGLGFAI | 265-273 | ４°C | ||||
|
|
TC-0151-1 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | ４°C | ||||
|
|
TC-0162-2 |
HLA-A*02:01 IGRP Tetramer-VLFGLGFAI-APC |
|
|||
|
|
Others | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLFGLGFAI | 265-273 | ４°C | ||||
|
|
TS-M120-4 |
HLA-A*02:01 PSA 141-150 Tetramer-FLTPKKLQCV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLTPKKLQCV | 141-150 | ４°C | ||||
|
|
TC-0122-2 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTRILTI | ４°C | |||||
|
|
TC-0177-2 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLQSLQTYV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLQSLQTYV | ４°C | |||||
|
|
TC-0169-1 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GVRGRVEEI | ４°C | |||||
|
|
TS-M047-4 |
HLA-A*02:01 HPV16 E6 Tetramer-KLPQLCTEL-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLPQLCTEL | 18-26 | ４°C | ||||
|
|
TS-0018-4C |
HLA-A*02:01 HBV core Tetramer-FLPSDFFPSV-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLPSDFFPSV | 18-27 | ４°C | ||||
|
|
TC-0110-4 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLLFLLFSL | ４°C | |||||
|
|
TC-0156-1 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| QLCPICRAPV | 175-184 | ４°C | ||||
|
|
TC-0127-4 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| AILALLPAL | 105-133 | ４°C | ||||
|
|
TS-M082-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLEPGPVTA | 280-288 | ４°C | ||||
|
|
TC-0110-1 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests | 1-9 | |
| SLLFLLFSL | ４°C | |||||
|
|
TC-0153-4 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | ４°C | ||||
|
|
TC-0128-4 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | ４°C | ||||
|
|
TC-0163-1 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | ４°C | ||||
|
|
TS-M059-4 |
HLA-A*02:01 AdV 11 Hexon 914-922 Tetramer-LLFEVFDVV-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFEVFDVV | 914-922 | ４°C | ||||
|
|
TC-0102-2 |
HLA-A*02:01 Insulin B Tetramer-HLVEALYLV-APC |
|
|||
|
|
Others | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| HLVEALYLV | ４°C | |||||
|
|
TC-0164-2 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | ４°C | ||||
|
|
TC-0135-1 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-PE |
|
|||
|
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLADQLIHL | 101-109 | ４°C | ||||
|
|
TC-0116-2 |
HLA-A*02:01 LCMV GPC 447-455 Tetramer-YLVSIFLHL-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLVSIFLHL | ４°C | |||||
|
|
TS-M078-4 |
HLA-A*02:01 MAGE-A10 Tetramer-GLYDGMEHL-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLYDGMEHL | ４°C | |||||
|
|
TC-0133-2 |
HLA-A*02:01 HTLV bZIP Tetramer-AVLDGLLSL-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| AVLDGLLSL | 42-50 | ４°C | ||||
|
|
TC-0156-2 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| QLCPICRAPV | 175-184 | ４°C | ||||
|
|
TC-0157-1 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | ４°C | ||||
|
|
TC-0163-4 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | ４°C | ||||
|
|
TC-0116-4 |
HLA-A*02:01 LCMV GPC 447-455 Tetramer-YLVSIFLHL-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLVSIFLHL | ４°C | |||||
|
|
TS-M076-4 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLWGPRALV | 271-279 | ４°C | ||||
|
|
TC-0118-4 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CVNGVCWTV-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| CVNGVCWTV | ４°C | |||||
|
|
TC-0120-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLEPGPVTV | ４°C | |||||
|
|
TS-M053-4 |
HLA-A*02:01 HBV pol Tetramer-FLLSLGIHL-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLSLGIHL | 575-583 | ４°C | ||||
|
|
TC-0150-4 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | ４°C | ||||
|
|
TS-0008-4C |
HLA-A*02:01 HIV pol Tetramer-ILKEPVHGV-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILKEPVHGV | 476-484 | ４°C | ||||
|
|
TC-0136-4 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | ４°C | ||||
|
|
TC-0161-4 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | ４°C | ||||
|
|
TS-M048-4 |
HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPETT-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMLDLQPETT | 11-20 | ４°C | ||||
|
|
TS-M070-2 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVLEYVIKV | 278-286 | ４°C | ||||
|
|
TC-0122-4 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTRILTI | ４°C | |||||
|
|
TC-0112-2 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLPLTVAEV | ４°C | |||||
|
|
TC-0154-4 |
HLA-A*02:01 HHV-8 gB Tetramer-LMWYELSKI-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMWYELSKI | ４°C | |||||
|
|
TC-0162-4 |
HLA-A*02:01 IGRP Tetramer-VLFGLGFAI-BV421 |
|
|||
|
|
Others | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLFGLGFAI | 265-273 | ４°C | ||||
|
|
TC-0173-2 |
HLA-A*02:01 HPV16 E7 Tetramer-MLDLQPETT-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| MLDLQPETT | 12-20 | ４°C | ||||
|
|
TS-M088-4 |
HLA-A*02:01 MUC1 Tetramer-LLLLTVLTV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLLTVLTV | 12-20 | ４°C | ||||
|
|
TC-0150-2 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | ４°C | ||||
|
|
TC-0152-1 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | ４°C | ||||
|
|
TC-0136-2 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | ４°C | ||||
|
|
TC-0165-4 |
HLA-A*02:01 Influenza M1 Tetramer-ILGFVFTLTV-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILGFVFTLTV | ４°C | |||||
|
|
TC-0152-2 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | ４°C | ||||
|
|
TS-M122-4 |
HLA-A*02:01 VZV IE62 Tetramer-ALWALPHAA-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALWALPHAA | 593-601 | ４°C | ||||
|
|
TC-0152-4 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | ４°C | ||||
|
|
TC-0112-1 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLPLTVAEV | ４°C | |||||
|
|
TC-0121-4 |
HLA-A*02:01 LCMV ND Tetramer-ALPHIIDEV-BV421 |
|
|||
|
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALPHIIDEV | ４°C | |||||
|
|
TC-0151-4 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | ４°C | ||||
|
|
TC-0118-2 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer CVNGVCWTV-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| CVNGVCWTV | ４°C | |||||
|
|
TC-0146-2 |
HLA-A*02:01 EBV LMP1 Tetramer-YLLEMLWRL-APC |
|
|||
|
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLEMLWRL | 125-133 | ４°C | ||||
|
|
TC-0113-2 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLFFYRKSV | ４°C | |||||
|
|
TC-0169-4 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-BV421 |
|
|||
|
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GVRGRVEEI | ４°C | |||||
- The availability is based on the information in Japan at 00:05, Jul 14, 2026 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.